These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

65 related articles for article (PubMed ID: 20546938)

  • 1. Antigen-specific therapy of EAE via intranasal delivery of filamentous phage displaying a myelin immunodominant epitope.
    Rakover IS; Zabavnik N; Kopel R; Paz-Rozner M; Solomon B
    J Neuroimmunol; 2010 Aug; 225(1-2):68-76. PubMed ID: 20546938
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental autoimmune encephalomyelitis induced with a combination of myelin basic protein and myelin oligodendrocyte glycoprotein is ameliorated by administration of a single myelin basic protein peptide.
    Leadbetter EA; Bourque CR; Devaux B; Olson CD; Sunshine GH; Hirani S; Wallner BP; Smilek DE; Happ MP
    J Immunol; 1998 Jul; 161(1):504-12. PubMed ID: 9647262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoimmunity against myelin oligodendrocyte glycoprotein is dispensable for the initiation although essential for the progression of chronic encephalomyelitis in common marmosets.
    Jagessar SA; Smith PA; Blezer E; Delarasse C; Pham-Dinh D; Laman JD; Bauer J; Amor S; 't Hart B
    J Neuropathol Exp Neurol; 2008 Apr; 67(4):326-40. PubMed ID: 18379435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Critical role of antigen-specific antibody in experimental autoimmune encephalomyelitis induced by recombinant myelin oligodendrocyte glycoprotein.
    Lyons JA; Ramsbottom MJ; Cross AH
    Eur J Immunol; 2002 Jul; 32(7):1905-13. PubMed ID: 12115610
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of MOG-stimulated Th1 type "light up" (GFP+) CD4+ T cells for the development of experimental autoimmune encephalomyelitis (EAE).
    Yura M; Takahashi I; Serada M; Koshio T; Nakagami K; Yuki Y; Kiyono H
    J Autoimmun; 2001 Aug; 17(1):17-25. PubMed ID: 11488634
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.
    Hjelmström P; Juedes AE; Fjell J; Ruddle NH
    J Immunol; 1998 Nov; 161(9):4480-3. PubMed ID: 9794370
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic relapsing experimental autoimmune encephalomyelitis with a delayed onset and an atypical clinical course, induced in PL/J mice by myelin oligodendrocyte glycoprotein (MOG)-derived peptide: preliminary analysis of MOG T cell epitopes.
    Kerlero de Rosbo N; Mendel I; Ben-Nun A
    Eur J Immunol; 1995 Apr; 25(4):985-93. PubMed ID: 7737302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acceleration of experimental autoimmune encephalomyelitis in interleukin-10-deficient mice: roles of interleukin-10 in disease progression and recovery.
    Samoilova EB; Horton JL; Chen Y
    Cell Immunol; 1998 Sep; 188(2):118-24. PubMed ID: 9756642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delineation of the minimal encephalitogenic epitope within the immunodominant region of myelin oligodendrocyte glycoprotein: diverse V beta gene usage by T cells recognizing the core epitope encephalitogenic for T cell receptor V beta b and T cell receptor V beta a H-2b mice.
    Mendel Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1996 Oct; 26(10):2470-9. PubMed ID: 8898962
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSV-1-mediated IL-1 receptor antagonist gene therapy ameliorates MOG(35-55)-induced experimental autoimmune encephalomyelitis in C57BL/6 mice.
    Furlan R; Bergami A; Brambilla E; Butti E; De Simoni MG; Campagnoli M; Marconi P; Comi G; Martino G
    Gene Ther; 2007 Jan; 14(1):93-8. PubMed ID: 16929354
    [TBL] [Abstract][Full Text] [Related]  

  • 11. T cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice during experimental autoimmune encephalomyelitis.
    Klehmet J; Shive C; Guardia-Wolff R; Petersen I; Spack EG; Boehm BO; Weissert R; Forsthuber TG
    Clin Immunol; 2004 Apr; 111(1):53-60. PubMed ID: 15093552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-IL-16 therapy reduces CD4+ T-cell infiltration and improves paralysis and histopathology of relapsing EAE.
    Skundric DS; Dai R; Zakarian VL; Bessert D; Skoff RP; Cruikshank WW; Kurjakovic Z
    J Neurosci Res; 2005 Mar; 79(5):680-93. PubMed ID: 15682385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The cytokine signature of MOG-specific CD4 cells in the EAE of C57BL/6 mice.
    Hofstetter HH; Karulin AY; Forsthuber TG; Ott PA; Tary-Lehmann M; Lehmann PV
    J Neuroimmunol; 2005 Dec; 170(1-2):105-14. PubMed ID: 16257061
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the bm12 class II mutation on proliferative and cytokine responses of encephalitogenic T cells in myelin oligodendrocyte glycoprotein (MOG)-induced experimental autoimmune encephalomyelitis.
    Gur H; Mendel I; Kerlero de Rosbo N; Ben-Nun A
    J Autoimmun; 1999 Aug; 13(1):3-10. PubMed ID: 10441162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice.
    Peron JP; Yang K; Chen ML; Brandao WN; Basso AS; Commodaro AG; Weiner HL; Rizzo LV
    J Neuroimmunol; 2010 Oct; 227(1-2):10-7. PubMed ID: 20580440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Involvement of neuropsin in the pathogenesis of experimental autoimmune encephalomyelitis.
    Terayama R; Bando Y; Yamada M; Yoshida S
    Glia; 2005 Nov; 52(2):108-18. PubMed ID: 15920728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H-2b mice: fine specificity and T cell receptor V beta expression of encephalitogenic T cells.
    Mendel I; Kerlero de Rosbo N; Ben-Nun A
    Eur J Immunol; 1995 Jul; 25(7):1951-9. PubMed ID: 7621871
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T cells specific for the myelin oligodendrocyte glycoprotein mediate an unusual autoimmune inflammatory response in the central nervous system.
    Linington C; Berger T; Perry L; Weerth S; Hinze-Selch D; Zhang Y; Lu HC; Lassmann H; Wekerle H
    Eur J Immunol; 1993 Jun; 23(6):1364-72. PubMed ID: 7684687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. IgG subclass switching is associated with the severity of experimental autoimmune encephalomyelitis induced with myelin oligodendrocyte glycoprotein peptide in NOD mice.
    Ichikawa M; Koh CS; Inaba Y; Seki C; Inoue A; Itoh M; Ishihara Y; Bernard CC; Komiyama A
    Cell Immunol; 1999 Feb; 191(2):97-104. PubMed ID: 9973531
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An MHC anchor-substituted analog of myelin oligodendrocyte glycoprotein 35-55 induces IFN-gamma and autoantibodies in the absence of experimental autoimmune encephalomyelitis and optic neuritis.
    Ford ML; Evavold BD
    Eur J Immunol; 2004 Feb; 34(2):388-97. PubMed ID: 14768043
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.